New suction tool aims to zap kidney stones faster and cleaner
NCT ID NCT07181759
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares a new surgical tool called VISOR to a standard scope for removing kidney stones. VISOR combines suction, pressure control, and laser to break up and remove stones in one step. About 100 adults with stones up to 3 cm will be randomly assigned to get either VISOR or standard surgery. The main goal is to see if VISOR leaves fewer stone fragments right after surgery and at 3 months, while keeping the kidney safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VISOR system (a surgical device that suctions stones and controls pressure during ureteroscopy)
What this could lead to
If it works, this could mean fewer leftover stone fragments and fewer complications for people undergoing kidney stone surgery.
What could go wrong
This is a small, early-stage trial with only 100 people, so results may not apply to everyone. The new device could also cause unexpected side effects like injury or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URETEROSCOPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••